Related Experiment Video
Updated: May 7, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young
Babak Pourakbari1, Farzad Ferdosian, Shima Mahmoudi
1Pediatrics Infectious Diseases Research Center, Tehran University of Medical Sciences , Tehran , Iran.
Insights
High rates of antimicrobial resistance and Extended-spectrum beta-lactamase producing Escherichia coli were found in pediatric urinary tract infections (UTI). Local surveillance is crucial for effective empirical therapy in children.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Antimicrobial Resistance
Background:
- Urinary tract infections (UTI) caused by Extended-spectrum beta-lactamase (ESBL) producing Escherichia coli are a growing global health concern.
- Increasing antimicrobial resistance limits treatment options for pediatric UTIs.
Purpose of the Study:
- To investigate the prevalence of antimicrobial resistance and ESBL production in E. coli isolates from pediatric UTI cases.
- To assess the susceptibility patterns of common antibiotics against these isolates.
Main Methods:
- Disk diffusion method was used to test antibiotic susceptibility of 100 E. coli isolates from pediatric UTI patients.
- Isolates were collected from patients aged 2 months to 12 years between April 2009 and March 2010.
Main Results:
- High resistance rates were observed for Trimethoprim/Sulfamethoxazole (84%), Cefalotin (66%), Cefuroxime (50%), Cefixime (50%), and Ceftriaxone (45%).
- Meropenem (98%), Amikacin (95%), and Nitrofurantoin (91%) showed high susceptibility.
- ESBL production was detected in 32% of community and 42% of nosocomial isolates.
Conclusions:
- Significant antimicrobial resistance and ESBL production in pediatric E. coli UTI isolates necessitate local surveillance.
- Findings highlight the need for region-specific data to guide empirical antibiotic therapy for pediatric UTIs.
Abstract:
Emerging antimicrobial resistance rates and Extended-spectrum beta-lactamase producing Escherichia coli recovered from urinary tract infections (UTI) is an increasing problem in specific regions, limiting therapeutic options. One hundred E. coli isolates causing UTI in patients with age from 2 months to 12 years admitted at CMC in the period of April 2009 to March 2010 were tested for antibiotic susceptibility using the disk diffusion method. Surprisingly high resistance rates were recorded for E. coli against TMP/SMX (84%), cefalotin (66%), cefuroxime (50%), cefixime (50%) and ceftriaxone (45%). Antimicrobial susceptibility of E. coli isolates was followed by meropenem (98%), amikacin (95%), nitrofurantoin (91%) and gentamicin (68%). Extended spectrum beta-lactamase production, was observed in 32% of community and 42% of nosocomial isolates. The results of this study and numerous observations regarding the increasing resistance to these antibiotics, in several countries, emphasize the need for local population-specific surveillance for guiding empirical therapy for UTI in children.
More Related Videos
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection I: Introduction
Mechanism of Antibiotic Resistance in MRSA
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Microbiota of the Urogenital Tract
Clinical Significance of Antibiotic Resistance

